A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Alberta Health Services (AHS) is Canada’s first and largest provincewide, fully-integrated health system, responsible for delivering health services to the more than 4.3 million people living in Alberta, as well as to some residents of Saskatchewan, B.C. and the Northwest Territories.
Alberta, Canada Clinical Trial Location
Cross Cancer Institute
11560 University Ave, Edmonton,
AB T6G 1Z2, Canada